Sera Prognostics (SERA) Competitor Comparison
We are evaluating the key criteria listed to compare Sera Prognostics (SERA) against its competitors in the Diagnostics & Research industry.
Market Capitalization
39 / 58Gross Profits
51 / 52Total Revenue
54 / 57EBITDA
43 / 56Free Cashflow
41 / 56Quick Ratio
21 / 57Earnings per Share
33 / 56Dividend yield
0 / 9Total Cash
40 / 57Performance 3 years
25 / 58Performance 5 years
38 / 58Performance 10 years
38 / 58Linearity 3 years
27 / 58Linearity 5 years
27 / 58Linearity 10 years
22 / 58Total Rank
49 / 58Dividend Rank
33 / 58Valuation Rank
46 / 58Piotroski Rank
45 / 58Muliplier Rank
33 / 58Piotroski Rank - SERA ranking 45 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.